The First Female Chief of Staff and an Early-Stage Cancer Diagnosis That Doesn’t Pause the Job
Susie Wiles’ decision to keep working reflects both medical progress and the quiet advantages of early detection.
What “early-stage” actually means
One stage, many diseases
The many paths after the same diagnosis
The incomplete promise of early detection
The infrastructure behind survival
Treating the tumor, accounting for the patient
When treatment fits into a workday
The most reassuring cancer diagnosis is the one found in time.
When Susie Wiles said she has early-stage breast cancer and plans to keep working, the message was simple: the cancer was caught early, her outlook is strong, and treatment will move forward.
What “early-stage” actually means
Early-stage breast cancer, usually stage I or II, means the tumor is still small. It is in the breast and may have spread only a little, if at all, to nearby lymph nodes.
This is when care can feel organized. A scan finds something unusual. A biopsy confirms cancer. Lab tests study the tumor. Doctors choose treatment step by step.
One stage, many diseases
But “early-stage” does not mean just one kind of cancer.
It is a group of different diseases that all have one thing in common: they were found before spreading far.
Some tumors grow slowly and respond to hormones like estrogen and progesterone. Others grow faster and act more aggressively. Doctors test for things like hormone receptors and HER2 to understand this.
Two people can have the same stage and need very different treatments.
Early detection makes the tumor easier to find. It does not make all tumors the same.
The many paths after the same diagnosis
Treatment often starts with surgery to remove the tumor.
After that, some patients get radiation. Some take hormone-blocking pills for years. Some need chemotherapy or targeted drugs.
Not everyone needs every treatment.
Doctors decide based on the tumor and the patient’s health. This is called personalized care.
It is precise, but it can also make things sound simpler than they really are.
The incomplete promise of early detection
It is true that finding cancer early leads to better outcomes.
But that is only part of the story.
Outcomes improve because the cancer is smaller and has not spread far. This makes treatment easier and more likely to work.
Doctors can aim to cure the cancer, not just control it.
The infrastructure behind survival
Early detection works only if the system works.
People need access to screening. They need to be able to get a mammogram without delay. If something is found, they need fast follow-up tests. A biopsy has to be scheduled, performed, and read accurately. Treatment has to begin without long gaps. And patients need the time, money, and support to complete it.
When all of this lines up, outcomes are excellent. Survival rates for early-stage breast cancer are often above 90-99% at five years.
But the system does not work the same way for everyone.
Some women are screened regularly. Others are screened late or not at all. Insurance status, geography, and health system access shape who gets routine mammograms and who does not.
Even after an abnormal result, delays are common. In some settings, patients wait weeks to months for follow-up imaging or biopsy. These delays are not random. They are more likely in under-resourced clinics, for patients without stable insurance, and for those navigating complex health systems without support.
Diagnosis is also not uniform. High-quality pathology and biomarker testing — such as estrogen and progesterone hormone receptor and HER2 status — are essential for choosing the right treatment. But access to these services can vary by hospital, region, and resources.
Treatment follows the same pattern.
Some patients receive care in well-coordinated centers where surgery, oncology, and radiation are tightly linked. Others move between disconnected providers, with delays at each step.
Some women can take time off work, afford medications, manage side effects, and return for repeated visits. Some can’t.
These differences show up in outcomes.
Black women in the United States, for example, are more likely to be diagnosed at later stages and have higher mortality rates, even when controlling for some clinical factors. Part of this reflects differences in tumor biology. Much of it reflects differences in access to timely, high-quality care.
Rural patients face longer travel times and fewer specialists. Lower-income patients are more likely to experience delays or incomplete treatment. Older patients may be undertreated, not because of biology, but because of assumptions about tolerance or life expectancy.
In this way, stage at diagnosis begins to reflect the system as much as the disease.
Early-stage cancer is where medicine works best. It is also where systems quietly decide who gets to arrive there.
Treating the tumor, accounting for the patient
At age 68, treatment decisions include more than just the cancer.
Doctors also think about overall health, other conditions, and how well a person can handle treatment.
Many older patients live long lives and may die from causes other than cancer.
This shifts the goal from the most treatment possible to the right amount of treatment.
When treatment fits into a workday
Susie Wiles saying she will keep working.
Most doctors aren’t surprised. Modern breast cancer care often allows it.
But it depends on the cancer being found early and treated under the right conditions.